Centene(US:CNC) Benzingaยท2024-12-12 17:41Financial Guidance - For fiscal year 2025, Centene Corporation expects total revenues between $166.5 billion and $169.5 billion, slightly above the consensus of $166.58 billion [1] - The guidance includes premium and service revenues projected at $154.0 billion to $156.0 billion [1] - The company anticipates GAAP EPS greater than $6.19 and adjusted EPS greater than $7.25, compared to the consensus of $6.97 [1] Health Benefits Ratio and Expenses - Centene expects a Health Benefits Ratio (HBR) of 88.4% to 89.0% for 2025 [2] - The forecast for selling, general, and administrative (SG&A) expense ratio is between 8.1% and 8.7%, with an adjusted SG&A expense ratio also in the same range [2] 2024 Guidance Reaffirmation - The company reaffirms its 2024 premium and service revenues guidance of $143.5 billion to $144.5 billion [3] - HBR guidance for 2024 is set at 88.3% to 88.5% [3] - Adjusted diluted EPS guidance for 2024 is greater than $6.80 [3] Company Mission and Operations - Centene is dedicated to delivering high-quality outcomes for over 28 million members, focusing on medically complex and historically underserved populations [4] - The company has improved core operations and invested in customer and provider experiences while meeting financial commitments [4] Stock Performance - CNC stock increased by 1.92%, reaching $57.99 during the last check on Thursday [6]